| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377606A1 Immunogenic cell surface proteins of helicobacter pylori |
| 01/07/2004 | EP1377605A2 Secreted streptococcus pneumoniae proteins |
| 01/07/2004 | EP1377604A2 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
| 01/07/2004 | EP1377596A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 01/07/2004 | EP1377320A2 Polynucleotide binding complexes comprising sterols and saponins |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377304A2 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377299A2 Transcutaneous immunostimulation |
| 01/07/2004 | EP1377287A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 01/07/2004 | EP1377275A2 Vaccine for modulating between t1 and t2 immune responses |
| 01/07/2004 | EP1377251A2 A cell therapy method for the treatment of tumors |
| 01/07/2004 | EP1377213A1 Method of predicting stroke evolution utilising mri |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0724436B1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 01/07/2004 | EP0681480B1 Recognin vaccines |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | CN1466466A Remedies for heart failure |
| 01/07/2004 | CN1466464A Novel remedies for cancer |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1465700A Hepatitis c virus tunic protein E2 gene capable of being total length expressed in E. coli, its coding protein and use |
| 01/07/2004 | CN1465597A Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition |
| 01/07/2004 | CN1465590A Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 01/07/2004 | CN1465403A Tetrodotoxin conjugate and medicine composition having same |
| 01/07/2004 | CN1465402A Recombination protein vaccine for preventing animal aphtha virus infection |
| 01/07/2004 | CN1465401A Process for preparing acellular short corynebacteria preparation |
| 01/07/2004 | CN1465400A Preparation and application for human carcino-embryonic antigen and cell differentiation antigen 40 ligand fused tumor vaccine |
| 01/07/2004 | CN1133423C Container with freeze-dried vaccine component |
| 01/06/2004 | US6675137 Method of data compression using principal components analysis |
| 01/06/2004 | US6673916 Phospholipase inhibitors |
| 01/06/2004 | US6673905 For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673826 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering of the skin comprising applying to the skin an oil in water emulsion containing allantoin, an anionic emulsifier and beeswax |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673604 Muscle cells and their use in cardiac repair |
| 01/06/2004 | US6673601 Plasmid; expression vector encodes glycoprotein |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673538 Methods and compositions for designing vaccines |
| 01/06/2004 | US6673357 Alkaloid glycoside for use as a medicament |
| 01/06/2004 | US6673356 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2004 | US6673355 Administering vaccine to pregnant women; prevention and diagnosis of gastroenteritis, cystic fibrosis, and diarrhea |
| 01/06/2004 | US6673353 Tuberculosis vaccine |
| 01/06/2004 | US6673350 Argleuleugluphetyrleualamet nonapeptide and t lymphocyte cell sample from melanoma subject; reacts with major histocompatibility complex; cancer, autoimmune disease, and infection diagnosis |
| 01/06/2004 | US6673349 Crosslinking; forming vaccines |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673346 Compositions and methods for the treatment of sepsis |
| 01/06/2004 | US6673345 Protein for use in the prevention of worm parasitic infection in animals; for use in veterinary medicine |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/06/2004 | US6673341 Inhibiting transforming growth factor (tgf-beta) mediated angiogenesis, thereby inhibiting the proliferative disease in vertebrate |
| 01/06/2004 | CA2142712C Bordetella bronchiseptica vaccine |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2047721C Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375519A2 Method for affecting cellular function using antibodies |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375512A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 01/02/2004 | EP1375511A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 01/02/2004 | EP1374910A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374901A1 Graft rejection suppressors |
| 01/02/2004 | EP1374896A1 Blood rheology improving agents |
| 01/02/2004 | EP1374894A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 01/02/2004 | EP1374893A1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 01/02/2004 | EP1374892A1 Medicament for the treatment of diseases due to infection by Neisseria Meningitidis |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373900A2 Renal cell carcinoma tumor markers |
| 01/02/2004 | EP1373537A2 Viral vectors |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373487A2 Regulation of human protein kinase-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373478A1 Attenuated live vaccine |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373475A2 Immunotherapy based on dendritic cells |
| 01/02/2004 | EP1373322A1 Novel compound for treatment of allergy and asthma |
| 01/02/2004 | EP1373321A2 Modified antibodies and methods of use |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373308A2 Multimerization of hiv-1 vif protein as a therapeutic target |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |